The crypto world entered another frenzy in September 2025, with investors asking the million-dollar question: what is the next 100x […] The post BullZilla Presale Surges to Stage 2A at $0.00003241 as Ripple and MEW Join the 100x Meme Coin Race appeared first on Coindoo.The crypto world entered another frenzy in September 2025, with investors asking the million-dollar question: what is the next 100x […] The post BullZilla Presale Surges to Stage 2A at $0.00003241 as Ripple and MEW Join the 100x Meme Coin Race appeared first on Coindoo.

BullZilla Presale Surges to Stage 2A at $0.00003241 as Ripple and MEW Join the 100x Meme Coin Race

2025/09/08 03:15
4 min read

The crypto world entered another frenzy in September 2025, with investors asking the million-dollar question: what is the next 100x meme coin? Meme coins and altcoins continue to dominate headlines, not just as jokes, but as tokens capable of delivering life-changing returns. 

Three names are making waves right now: BullZilla, Ripple, and Cat in a Dog’s World (MEW), each offering something unique for investors searching for momentum. But one project, powered by an explosive presale model, is rapidly becoming the most talked-about 100x meme coin.

BullZilla: The Presale Beast Targeting 100x Meme Coin Status

BullZilla has quickly risen to prominence as a 100x meme coin candidate thanks to its high-octane presale model. Now in Stage 2A, priced at $0.00003241, Bull Zilla has already raised over $200K, with more than 700 holders and billions of tokens sold. Its progressive Mutation Engine ensures the presale price increases every 48 hours or whenever $100,000 is raised, rewarding conviction while punishing hesitation.

The projected listing price of $0.00527 translates to a staggering 20,000%+ ROI potential, positioning BullZilla as not only the best crypto to buy today but also a strong candidate for the next 100x meme coin. With its lore-driven Roar Burn mechanism, 70% APY staking furnace, and community-powered ecosystem, investors who buy BullZilla $BZIL at this stage could lock into a rare early opportunity that few meme coins ever offer.

Ripple: Utility Meets Growing Institutional Demand

While Bull Zilla fuels the hype-driven 100x meme coin narrative, Ripple (XRP) is making its mark with institutional utility. Ripple has seen renewed optimism following legal clarity in the U.S. and adoption by several banking giants for cross-border settlements. Priced steadily between $0.50 and $0.60, Ripple may not match BullZilla’s presale ROI potential, but it brings stability that meme coins often lack.

Recent forecasts suggest Ripple could target $1.50–$2.00 by 2026, with adoption in Asia and the Middle East accelerating its use case. For investors balancing speculative high-risk meme plays like BullZilla with utility-driven growth, Ripple remains a strong diversification option, even if it doesn’t fit the 100x meme coin mold.

Cat in a Dog’s World (MEW): Viral Momentum in Solana’s Meme Scene

Another contender in the conversation for top 100x meme coin is Cat in a Dog’s World (MEW). Built on Solana, MEW represents a viral shift in the meme coin meta, combining nostalgic humor with Solana’s low-fee, high-speed transactions. Recently, MEW surged past $650 million market cap, proving it’s more than a passing fad.

Analysts believe MEW could reach a $1 billion market cap in 2025, particularly if Solana continues its rise as a leading blockchain for meme culture. While not as early as BullZilla’s presale phase, MEW shows how community-driven storytelling can drive sustained gains in the meme sector, cementing its position alongside candidates for the next 100x meme coin breakout.

Conclusion: Which Project is the Next 100x Meme Coin?

For investors asking what is the next 100x meme coin, the answer may depend on risk appetite. Ripple offers long-term utility, Cat in a Dog’s World delivers viral community momentum, but BullZilla Presale stands out as the clearest candidate for explosive short-term and long-term gains. With the presale tally surging past $181K, and price jumps baked in every 48 hours, the urgency is clear: early entry is everything.

The meme coin market has always rewarded conviction over hesitation, and if history is any guide, BullZilla ($BZIL) next 1000x could be the headline that defines September 2025.

For More Information: 

BZIL Official Website

Join BZIL Telegram Channel

Follow BZIL on X  (Formerly Twitter)

FAQs

Q1: What stage is BullZilla’s presale currently in?

A1: BullZilla is in Stage 2A, priced at $0.00003241, with over $200K raised.

Q2: What makes BullZilla a 100x meme coin candidate?

A2: Its presale model, progressive price increases, Roar Burn mechanism, and staking furnace position it for massive ROI potential.

Q3: How is Ripple performing right now?

A3: Ripple’s price remains tied to regulatory clarity but continues to be one of the best crypto to buy today for utility-based adoption.

Q4: Why is Cat in a Dog’s World gaining traction?

A4: MEW has become one of the most trending meme coins 2025, driven by strong community support and viral cultural appeal.


This publication is sponsored. Coindoo does not endorse or assume responsibility for the content, accuracy, quality, advertising, products, or any other materials on this page. Readers are encouraged to conduct their own research before engaging in any cryptocurrency-related actions. Coindoo will not be liable, directly or indirectly, for any damages or losses resulting from the use of or reliance on any content, goods, or services mentioned. Always do your own research.

The post BullZilla Presale Surges to Stage 2A at $0.00003241 as Ripple and MEW Join the 100x Meme Coin Race appeared first on Coindoo.

Market Opportunity
cat in a dogs world Logo
cat in a dogs world Price(MEW)
$0.0006303
$0.0006303$0.0006303
-1.54%
USD
cat in a dogs world (MEW) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

And the Big Day Has Arrived: The Anticipated News for XRP and Dogecoin Tomorrow

And the Big Day Has Arrived: The Anticipated News for XRP and Dogecoin Tomorrow

The first-ever ETFs for XRP and Dogecoin are expected to launch in the US tomorrow. Here's what you need to know. Continue Reading: And the Big Day Has Arrived: The Anticipated News for XRP and Dogecoin Tomorrow
Share
Coinstats2025/09/18 04:33
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Rising Altcoin Inflows Signal Potential Market Sell-Off: CryptoQuant

Rising Altcoin Inflows Signal Potential Market Sell-Off: CryptoQuant

        Highlights:  Inflows of altcoins in exchanges have surged by 22% in early 2026. An increase in deposits indicates a growing sell-side pressure. The 
Share
Coinstats2026/02/22 02:03